The role and therapeutic potential of DNA glycosylases in Alzheimer's disease
Ageing Research Reviews · 2026-06 · 118 · 103129
DOI: 10.1016/j.arr.2026.103129 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-06. Verfasst von Xia Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China. Electronic address: xiazhao@hmc.edu.cn. Hauptthemen laut MEDLINE: Alzheimer Disease, DNA Glycosylases, Brain. Die Arbeit nennt 156 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Guangzhou Medical University, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
The aging brain is highly vulnerable to oxidative genomic damage, the accumulation of which is a hallmark of Alzheimer's disease (AD). The base excision repair (BER) pathway, initiated by DNA glycosylases, serves as the primary guardian against such damage. This review synthesizes recent evidence revealing the dual and dynamic roles of key DNA glycosylases including OGG1, MUTYH, MPG, and members of the NEIL family in AD pathogenesis. Beyond canonical repair functions, these enzymes actively participate in core pathological processes including Aβ/tau toxicity, neuroinflammation, and neuronal death, with their activities modulated by the AD microenvironment. We evaluate the therapeutic strategies targeting these enzymes, highlighting emerging strategies like OGG1 agonists for early-stage repair enhancement and inhibitors for dampening maladaptive inflammation in later stages. Finally, we propose a precision medicine approach based on a deeper understanding of glycosylase biology in distinct brain cell types and disease stages, providing a theoretical foundation for DNA repair-targeted interventions in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China. Electronic address: xiazhao@hmc.edu.cn.
- School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China.
- The First People's Hospital of Lin'an District, Affiliated Lin'an People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
- School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, C…
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Guangzhou Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zhao, X., Li, Y., Meng, Z., Xu, X., Chen, L., Yu, Q., Wang, R., Ren, Y., Chen, F., Ai, Q., Deng, Y., Yu, H., Wei, J., & Liang, G. (2026). The role and therapeutic potential of DNA glycosylases in Alzheimer's disease. Ageing Research Reviews, 118, 103129. https://doi.org/10.1016/j.arr.2026.103129
Vancouver
Zhao X, Li Y, Meng Z, Xu X, Chen L, Yu Q, et al. The role and therapeutic potential of DNA glycosylases in Alzheimer's disease. Ageing Research Reviews. 2026;118:103129. doi:10.1016/j.arr.2026.103129
BibTeX
@article{Zhao2026,
author = {Zhao, Xia and Li, Yingzhou and Meng, Ziyao and Xu, Xiaoxia and Chen, Linjie and Yu, Qin and Wang, Ruya and Ren, Yiyu and Chen, Fan and Ai, Qi and Deng, Yu and Yu, Houming and Wei, Jurui and Liang, Guang},
title = {The role and therapeutic potential of DNA glycosylases in Alzheimer's disease},
journal = {Ageing Research Reviews},
year = {2026},
volume = {118},
pages = {103129},
doi = {10.1016/j.arr.2026.103129}
}
EUVIMED